Cipla Share Price Live Updates: Cipla's 1-Month Return Overview
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 days ago
- Time of India
Cipla Share Price Live Updates: Cipla Sees a 1.13% Drop in Weekly Returns
11 Aug 2025 | 09:24:42 AM IST Welcome to the Cipla Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent stock. Dive into the current details of Cipla, including: Last traded price 1491.3, Market capitalization: 120022.12, Volume: 60024, Price-to-earnings ratio 22.26, Earnings per share 66.76. Our liveblog offers a complete overview of Cipla through a blend of fundamental and technical indicators. Stay informed about breaking news that can shape Cipla's performance in the market. Our market analysis and expert opinions empower you to make informed investment decisions. Join us as we unravel the potential of Cipla in the ever-changing market landscape. The data points are updated as on 09:24:42 AM IST, 11 Aug 2025 Show more
Time of India
5 days ago
- Time of India
Cipla Share Price Live Updates: Cipla Sees Increased Market Activity
08 Aug 2025 | 09:26:31 AM IST Welcome to the Cipla Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a prominent stock. Dive into the current details of Cipla, including: Last traded price 1486.1, Market capitalization: 120442.18, Volume: 33250, Price-to-earnings ratio 22.34, Earnings per share 66.76. Our liveblog offers a complete overview of Cipla through a blend of fundamental and technical indicators. Stay informed about breaking news that can shape Cipla's performance in the market. Our market analysis and expert opinions empower you to make informed investment decisions. Join us as we unravel the potential of Cipla in the ever-changing market landscape. The data points are updated as on 09:26:31 AM IST, 08 Aug 2025 Show more
Time of India
7 days ago
- Time of India
Pharma stocks in focus as Trump warns tariffs could hit 250%
Pharma stocks such as Sun Pharma , Cipla , Dr Reddy's Laboratories , Lupin , and others will be in focus on Wednesday after US President Donald Trump said tariffs on imported pharmaceuticals could rise to as high as 250%. The proposed tariffs would start at a lower rate but escalate over time, he said in a CNBC interview. 'We'll be putting an initially small tariff on pharmaceuticals, but in one year, one-and-a-half years, maximum, it's going to go to 150% and then 250%, because we want pharmaceuticals made in our country,' Trump said. He did not specify the initial tariff rate. Productivity Tool Zero to Hero in Microsoft Excel: Complete Excel guide By Metla Sudha Sekhar View Program Finance Introduction to Technical Analysis & Candlestick Theory By Dinesh Nagpal View Program Finance Financial Literacy i e Lets Crack the Billionaire Code By CA Rahul Gupta View Program Digital Marketing Digital Marketing Masterclass by Neil Patel By Neil Patel View Program Finance Technical Analysis Demystified- A Complete Guide to Trading By Kunal Patel View Program Productivity Tool Excel Essentials to Expert: Your Complete Guide By Study at home View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo Trump also indicated plans to impose tariffs on semiconductors and chips in the 'next week or so,' though no details were provided. Also Read: PNB Housing Finance, RBL Bank among 10 small-cap stocks where FIIs increased stake in Q1 The US administration has been pushing to bring pharmaceutical manufacturing back to domestic soil. Trump has threatened steep tariffs and demanded major drug suppliers cut costs or face further penalties. Live Events The United States is currently conducting a national security review of the pharmaceutical sector, with potential sector-specific tariffs under consideration. However, no timeline has been given for the release of the probe's findings. Currently, tariffs on pharmaceuticals and semiconductors between the US and the EU are set at zero under a framework agreement. However, if the US imposes new tariffs after its import investigation, these will be capped at 15% under the existing agreement. Also Read: These 10 stocks delivered consistent dividend yields over the last 3 years
